FLEXIBLE SOLUTIONS INTERNATIONAL INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FLEXIBLE SOLUTIONS INTERNATIONAL INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $15.49M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $16.25M | Apr 2, 2018 |
| FY2012 | Dec 31, 2012 | $16.40M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $15.52M | Apr 1, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.52M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $38.23M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $38.32M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $45.84M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $34.42M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $31.41M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $27.44M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $17.83M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $15.49M | May 17, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $15.49M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $16.25M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $15.90M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $15.91M | Mar 29, 2016 |
| FY2014 | Dec 31, 2013 | $15.80M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $16.40M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $15.52M | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | $11.49M | Mar 29, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.54M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $13.24M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $10.44M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $13.87M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $11.40M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.77M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $8.62M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $5.64M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $5.99M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $6.99M | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $786.9K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $3.04M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $2.78M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $7.02M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $3.45M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.98M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $1.91M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.49M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.75M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $1.79M | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.60M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $5.52M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $3.50M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $7.05M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $5.48M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $4.12M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $1.91M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.31M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.51M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $3.09M | Apr 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $615.3K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $330.0K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $158.2K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $99.3K | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $116.4K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $81.4K | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $123.7K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $135.9K | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $98.9K | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $95.1K | Apr 2, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.64M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $2.85M | Apr 15, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.78M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $5.57M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $6.12M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.48M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $4.54M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $5.71M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $2.37M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($2.23M) | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.04M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $1.78M | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.37M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $4.96M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $4.99M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.98M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $782.2K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.08M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $1.83M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $180.8K | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $426.5K | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $114.3K | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.83M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $59.97M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $55.47M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $51.59M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $39.55M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $35.09M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $32.38M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $31.20M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $17.77M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $15.16M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.00M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $18.60M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $17.20M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $16.35M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $11.85M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $11.32M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $11.92M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $11.67M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $2.85M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $2.69M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.91M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $38.03M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $35.20M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $32.63M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $25.10M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $21.21M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $17.91M | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | $17.06M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $14.92M | May 26, 2020 |
| FY2018 | Dec 31, 2016 | $12.46M | May 17, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.53M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $2.53M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $2.53M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.53M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $2.53M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.53M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $2.53M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.53M | May 26, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.35M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $19.84M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $18.05M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $15.90M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | $8.88M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $5.43M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $2.46M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.94M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $451.6K | May 17, 2019 |
| FY2017 | Dec 31, 2016 | ($1.30M) | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $7.63M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $5.02M | Mar 31, 2025 |
| FY2021 | Dec 31, 2021 | $5.71M | May 13, 2022 |
| FY2021 | Dec 31, 2020 | $3.47M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | $3.63M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $7.86M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | $6.91M | May 17, 2019 |
| FY2018 | Dec 31, 2016 | $2.47M | May 17, 2019 |
| FY2017 | Dec 31, 2015 | $2.50M | Apr 2, 2018 |
| FY2015 | Dec 31, 2014 | $747.5K | Mar 29, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.44M | Apr 15, 2026 |
| FY2024 | Dec 31, 2024 | $8.76M | Mar 31, 2025 |
| FY2023 | Dec 31, 2023 | $8.11M | Aug 13, 2024 |
| FY2023 | Dec 31, 2022 | $6.15M | Aug 13, 2024 |
| FY2023 | Dec 31, 2021 | $2.37M | Aug 13, 2024 |
| FY2022 | Dec 31, 2020 | $3.85M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $4.38M | May 13, 2022 |
| FY2020 | Dec 31, 2018 | $4.35M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $352.1K | May 26, 2020 |
| FY2018 | Dec 31, 2016 | $553.3K | May 17, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
| FY2012 | Dec 31, 2012 | 0 | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | 0 | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | 0 | Mar 29, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
| FY2012 | Dec 31, 2012 | 0 | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | 0 | Apr 1, 2013 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.72M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 12.52M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 12.44M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 12.43M | Aug 13, 2024 |
| FY2022 | Dec 31, 2021 | 12.36M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 12.26M | May 13, 2022 |
| FY2020 | Dec 31, 2019 | 12.22M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 11.70M | May 26, 2020 |
| FY2018 | Dec 31, 2017 | 11.60M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | 11.46M | Apr 2, 2018 |